Tag Archives: BIIB

Top 10 Biotech Stocks To Own Right Now

The Dow Jones Industrial Average came close to hitting 20,000, but fell short again…nearly four weeks after Barron’s wrote about the possibility in a cover story on Dec. 10.

Getty Images

The S&P 500 rose 0.4% to 2,276.98 today, a record high. The Nasdaq Composite, meanwhile, gained 0.6% to 5,521.06, also a record. The Dow Jones Industrial Average advanced 64.51 points,....More>>>

Best Biotech Stocks To Own Right Now

Right now, there’s a major shift underway in the biotech field that’s creating a brand-new $59.2 billion industry. And investors who get in now could be positioning themselves for triple- or even quadruple-digit gains…

That’s why we’re bringing readers one of the best biotech stocks to buy in December 2017, according to Money Morning Director of Technology....More>>>

Top 5 Biotech Stocks For 2018

With the Allergan (AGN)-Pfizer (PFE) merger scuttled by those pesky new Treausry rules on tax inversions, Allergan will have a lot of cash on hand to go shopping. Who will it buy? Citigroup’s Liav Abraham and Yigal Nochomovitz have ideas:

Brendan McDermid /Reuters

Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company....More>>>

Top 10 Biotech Stocks To Invest In 2018

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Some of the biggest gainers among Manufacturing stocks include:

Flex Pharma Inc Cmn (FLKS): FLKS stock is up 13.55% today. Egalet Corporation (EGLT): EGLT stock is up 12.41% today. Versartis Inc Cmn (VSAR): VSAR stock is up 10.15% today. Dynavax Technologies (DVAX): DVAX stock....More>>>

Top 10 Tech Stocks To Invest In 2018

One of the richest men in China has made a big bet on an icon of Europe’s automotive industry.

Li Shufu, the billionaire chairman of Chinese car maker Geely (GELYF), invested about $9 billion buying a stake of almost 10% in Daimler (DDAIF), making him the biggest single shareholder in the owner of Mercedes Benz.

Li, who’s estimated to be worth around $18 billion, has....More>>>

Top 10 High Tech Stocks To Invest In 2019

In no uncertain terms, Snap’s (NYSE:SNAP) first shot at hardware was an utter disaster in just about every way imaginable. Snap ordered far too many units, which resulted in inventory writedowns and other costs associated with canceling its purchase commitments with suppliers. Meanwhile, the company also lost money on each unit sold, and the product failed to generate any type of meaningful....More>>>

Hot Biotech Stocks To Buy For 2018

Deals and Financings

China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets under management currently to $10 billion over the next three years. At the moment, the company runs two funds: Huaxing Growth Capital, focused on technology, media and entertainment, and Huaxing Healthcare. The company plans....More>>>

Best Biotech Stocks To Buy Right Now

On Tuesday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotechnology stock Threshold Pharmaceuticals (NASDAQ: THLD) as a long trade:

The chart below speaks for itself. After trying to work its way above a ceiling at $0.62 for the past several months, that finally happened today, in earnest. Better still, it’s happened after a strong foundation was laid,....More>>>

Best Biotech Stocks To Watch For 2018

What happened

Shares of Novavax, Inc. (NASDAQ:NVAX), a clinical-stage biotech developing vaccines, have risen about 10.7% as of 3:05 p.m. EDT on Thursday. A positive response to the company’s earnings pushed the stock up a couple days ago, but Thursday’s bump comes in response to recent insider share purchases.

So what

Earlier Thursday morning Novavax filed a....More>>>

Hot Biotech Stocks To Watch For 2019

Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin....More>>>

Top 5 Bank Stocks To Watch For 2018

Argentine President Mauricio Macri said he will reduce the nation’s fiscal deficit at a faster pace as part of an agreement with the IMF, while acknowledging that inflation targeting had been too ambitious.

An eventual deal with the International Monetary Fund will restore confidence and ensure long-term economic growth, Macri told reporters on Wednesday, following a 23 percent slump....More>>>

Top 5 Biotech Stocks To Invest In 2018

What happened

ImmunoGen (NASDAQ:IMGN) is up 21.8% at 1:06 p.m. EST on no apparent news. Of course, it’s a biotech, so that’s often par for the course.

So what

One possibility is that day traders are just doing their thing, following the momentum, which pushes the stock price higher. We’ll know in a few days if the share price returns to previous levels.


Best Biotech Stocks To Own Right Now

With hundreds of biotech stocks on the market, who can keep up with them all? Probably no one. What happens as a result is that usually only the biggest biotechs (or the small biotechs getting bought by the biggest biotechs) get a lot of coverage.But sometimes those aren’t the stocks to watch most closely.

You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin....More>>>

Hot Biotech Stocks To Own Right Now

Investment company Parkside Investments, LLC buys iShares Core MSCI EAFE, Alerian MLP, SPDR Select Sector Fund – Consumer Discretionary, iShares Nasdaq Biotechnology Index Fund, Alibaba Group Holding, Platform Specialty Products Corp, SPDR S&P Oil & Gas Explor & Product, SPDR Nuveen Bloomberg Barclays Short Term Municipa, Citigroup Inc, Discovery Communications Inc, sells SPDR....More>>>

Top 10 Biotech Stocks To Buy Right Now

It has been over two years since I wrote Acceleron Pharma (XLRN) Has Two Potential Blockbusters, so an update is in order. Back then, on July 22, 2015, Acceleron closed at $32.18. It has been very volatile in the meantime, hitting $50.49 on December 29, 2015, but also $21.99 on October 13, 2015. That is part of the thrill (or opportunity, or danger) of investing in clinical-state biotechnology companies.....More>>>